Go back to Resource Center
Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics
2004
Journal Article
Authors:
Csaky, K.;
Group, C.P.D.T.1Study Rese
Location: Ft. Lauderdale, FL
Go back to Resource Center